S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia

Plain-language summary

This is a laboratory study that examines bone marrow samples from women with acute myeloid leukemia (AML) using methods such as gene expression analysis and flow cytometry. The samples came from women with untreated AML undergoing intensive induction chemotherapy. It was carried out as a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

SWOG Cancer Research Network

Intervention

gene expression analysis, flow cytometry, fluorescence activated cell sorting, laboratory biomarker analysis, medical chart review

Start date

4/1/2012

Estimated completion

5/1/2012

Related genes

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

DISEASE CHARACTERISTICS:

* Diagnostic bone marrow specimens from female patients with untreated AML undergoing intensive ("3+7"-like) induction chemotherapy
* Specimens from the South Western Oncology Group (SWOG) protocols S0106 (age 18 to 60 years), excluding patients who received gemtuzumab ozogamicin (GO), and S9333 (age \> 60 years)

PATIENT CHARACTERISTICS:

* See Disease Characteristics

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics